Brands and Their Owners
Welcome to the Brand page for “BLYSSIENT”, which is offered here for Column 1, line 7 metabolism, and should be deleted. column 1, line 17 infectious, viral and oncological should be deleted. the following all these products not related to immune or autoimmune disease or disorders should be inserted end of the class.;pharmaceutical preparations for the treatment of diseases and disorders of the alimentary tract and [ metabolism, and ] blood and blood forming organs; pharmaceutical preparations for the treatment of diseases and disorders of cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system and respiratory system; pharmaceutical preparations for the treatment of dermatological, hormonal, [ infectious, viral and oncological ] diseases and disorders; * all these products not related to immune or autoimmune disease or disorders *;.
Its status is currently believed to be active. Its class is unavailable. “BLYSSIENT” is believed to be currently owned by “Boehringer Ingelheim International GmbH”.
Owner: |
BOEHRINGER INGELHEIM INTERNATIONAL GMBH
Owner Details |
---|---|
Description: |
Column 1, line 7 metabolism, and should be deleted. Column 1, line 17 infectious, viral and oncological should be deleted. The following all these products not related to immune or autoimmune disease or disorders should be inserted end of the class.;Pharmaceutical preparations for the treatment of diseases and disorders of the alimentary tract and [ metabolism, and ] blood and blood forming organs; pharmaceutical preparations for the treatment of diseases and disorders of cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system and respiratory system; pharmaceutical preparations for the treatment of dermatological, hormonal, [ infectious, viral and oncological ] diseases and disorders; * all these products not related to immune or autoimmune disease or disorders *;
|
Categories: | COLUMN |